Gladstone Institutes plans to launch two new biomedical research institutes in San Francisco to broaden its impact on unsolved diseases, including COVID-19.
Under the leadership of Dr. Melanie Ott, Gladstone Institute of Virology will study COVID-19 and study novel therapies against future infectious diseases. Researchers will focus on the way viruses interact with human host cells to cause disease and how to intervene in that process.
The other facility, which is a partnership between Gladstone and the University of California, San Francisco (UCSF), is the Gladstone-UCSF Institute of Genomic Immunology. Led by Dr. Alexander Marson, this facility will work to better understand the genetic control of human immune cells and develop novel cell-based immunotherapies.